BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AGAH - ECPv5.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AGAH
X-ORIGINAL-URL:https://dev.agah.eu
X-WR-CALDESC:Events for AGAH
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210301
DTEND;VALUE=DATE:20210304
DTSTAMP:20260929T023133
CREATED:20210111T110813Z
LAST-MODIFIED:20210111T111238Z
UID:4432-1614556800-1614815999@dev.agah.eu
SUMMARY:6. German Pharm-Tox Summit 2021 – AGAH-Symposium: Clinical and economic aspects of medical application of biologics
DESCRIPTION:6. German Pharm-Tox Summit 2021 (virtual)\n \n\n\n\n	PROGRAM \nWebsite Conference \nAGAH Symposium: Wednesday\, 3/3/2021\, 12:45-13:45\n \n"Clinical and economic aspects of medical application of biologic" \n\n\n\n\n12:45\n\nTargets and collateral damage in rheumatoid arthritis\n Ingolf Cascorbi (Kiel/DE) \nTalk time: 12 + 8 min \n\n\n\n\n\n\n\n\n\n\n\n13:05\n\nSingle\, very low rituximab doses in healthy volunteers – implications for dosing and biosimilarity testing\n Bernd Jilma (Wien/AT) \nTalk time: 12 + 8 min \n\n\n\n\n\n\n\n\n\n\n\n13:25\n\nClinical and economic decision\n Dominic Fenske (Erfurt/DE) \nTalk time: 12 + 8 min\n\n\n\n\n\n\n\n	REGISTRATION \nOnline Registration\n \n  \n\n\n\n\n	CONTACT \nWebsite
URL:https://dev.agah.eu/event/6-german-pharm-tox-summit-2021-agah-symposium-clinical-and-economic-aspects-of-medical-application-of-biologics-2/
CATEGORIES:Annual Meetings,Training
ORGANIZER;CN="DGPT%20e.%20V.":MAILTO:Mitglieder@dgpt-online.de
END:VEVENT
END:VCALENDAR